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Abstract
Post-traumatic stress disorder (PTSD) is a widespread psychiatric injury that develops
serious life-threatening symptoms like substance abuse, severe depression, cognitive impairments
and persistent anxiety. However, the mechanisms of post-traumatic stress injury in brain is poorly

understood due to the lack of practical methods to reveal biochemical alterations in various brain
regions affected by this type of injury. Here, we introduce a novel method that provides
quantitative results from Raman maps in paraventricular nucleus of the thalamus (PVT) region.
By means of this approach, we have shown a lipidome comparison in PVT regions of control and
PTSD rat brains. Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry was also
employed for validation of the Raman results. Lipid alterations can reveal invaluable information
regarding the PTSD mechanisms in affected regions of brain. We have showed that the
concentration of cholesterol, cholesteryl palmitate, phosphatidylinositol, phosphatidylserine,
phosphatidylethanolamine, sphingomyelin, ganglioside, glyceryl tripalmitate and sulfatide
changes in the PVT region of PTSD compared to control rats. Higher concentration of cholesterol
suggests the higher level of corticosterone in brain.1 Moreover, concentration changes of
phospholipids and sphingolipids suggest the alteration of phospholipase A2 (PLA2) which is
associated with inflammatory processes in the brain. Our results have broadened the understanding
of biomolecular mechanisms for PTSD in PVT region of brain. This is the first report regarding
the application of Raman spectroscopy for PTSD studies. This method has a wide spectrum of
applications and can be applied to various other brain related disorders or other regions of brain.
Keyword: Raman Imaging; Raman Spectroscopy; Post-traumatic stress disorder; Paraventricular
nucleus of the thalamus; Lipidome study; Lipidome quantification
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1. Introduction
Lipids play an important role in the brain through their homeostasis to maintain the
integrity of the cell membranes and control the signaling through the membranes.2, 3 Changes in
brain lipids have been correlated with many neurological diseases4, 5 such as Alzheimer's disease,6,
7

Parkinson's disease,8, 9 and schizophrenia.10, 11 Structurally, brain tissues are composed of about

5-15% lipids that may account for 50% of the dry weight of the brain.12 Mass spectrometry has
been the gold standard for lipidomics analysis and has been accurately applied to cells tissues and
whole organisms.13-16 Most classical lipidome analysis requires extraction and homogenization of
the sample, which results in a loss of spatial localization. Immunohistochemistry based methods
preserve the spatial information. However, this is a targeted method and the target lipids must be
known in advance to select an appropriate antibody for staining. Also, the number of dyes available
for staining the lipids are limited. Further, multiplexing is difficult with the histochemical
approach. For example, only one or two antibodies can be applied simultaneously on the same
sample.
Both matrix-assisted laser desorption/ionization (MALDI) based mass spectrometry and
Raman spectroscopy can alleviate many of the limitations listed above. Raman spectroscopy has
additional advantages over MALDI such as Raman spectroscopy is non-destructive and no matrix
is needed. In addition, Raman spectroscopy requires minimal sample preparation. Raman
spectroscopy has become a ubiquitous method for molecular level analysis of various biological
samples such as brain,17-20 heart,21-23 kidney,24-26 lipids,27, 28 and proteins29-31 due to the noninvasive and label-free nature of it. Among these, Raman spectroscopy of lipids has attracted
particular attention in the field because of the strong Raman scattering of lipids provided by long
nonpolar acyl chains in their structure.27 It is well-established that lipids play significant role in
3

different cellular functions such as transport in cell membranes, signaling and energy storage.32
Therefore, the Raman signal obtained from the lipid bands of cells could be utilized as pathological
biomarkers. Although there are similarities in the Raman spectrum of different lipids, individual
lipids possesses unique spectra depending on numerous factors including geometry, phase,
solubility, saturation, and polymorphism.33 Lipids have Raman bands in both the fingerprint (4001800 cm−1) and higher wavenumber group frequency regions (2400–3800 cm−1).34 The most
typical characteristics of lipids which originate from hydrocarbon chains manifest themselves in
1200-1050 cm-1 (C-C stretch), 1250-1300 cm-1 (CH3 scissor and twist) and 1400-1500 cm-1 (CH2
scissor and twist) ranges.35 At higher wavenumbers, strong Raman bands appear in the 2800-3100
cm-1 region which is assigned to C-H stretching of lipids.27
Post-traumatic stress disorder (PTSD) is considered a prevalent psychiatric disorder caused
by exposure to repeated or single life-threatening events such as individuals involved in traffic
accidents, combat veterans and rape victims.36 PTSD patients relive traumatic event by sudden
remembrance of traumatic memories or flashbacks originating from the extreme horror and
feelings of helplessness caused by the traumatic event. People with PTSD develop psychiatric
disorders and symptoms such as severe depression, substance abuse, cognitive impairments, and
persistent anxiety.37 Controlled biological investigations of PTSD in human subjects are mostly
restricted due to ethical and logistical issues. Thus, indirect neurobiology studies on post-traumatic
stress injured brains have become conventional by means of translational animal model
approaches.38, 39 As a result, many studies have been carried out by exposing animals to acute or
chronic stress conditions to study their physiology and behavior changes which provide valuable
knowledge under conditions similar to that experienced by traumatized human subjects. Although
traumatic memories can develop into PTSD, it is not the only influential factor involved in
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constructing an effective animal model due to multidimensional nature of this disease.40
Accordingly, various animal models such as predator stress, inescapable shocks, single prolonged
stress, and unpredictable variable stress have been developed to ensure the occurrence of severe
fear stress and production of human-like biological and behavioral symptoms in animals.41
It is well-known that severe stress exposure negatively affects various parts of brain which
are responsible for emotional responses, memory, and decision-making functions.42-45 Numerous
morphological and functional deteriorations in various regions of their brain including the
hippocampus, prefrontal cortex, amygdala and thalamus have been observed in animal models
exposed to prolonged stress conditions.42, 46 Since physiological and behavioral symptoms of
PTSD in brain and their connection is crucial to thoroughly comprehending this type of disorder.
However, most of the studies in this field have been directed toward the hippocampus and
prefrontal cortex regions and the other parts are frequently neglected due to complexity.47-50 The
paraventricular nucleus of the thalamus (PVT) is one of the stress sensors in mammalian brains
that has been recently examined for its correlation to post-traumatic stress disorders.51 According
to recent studies,52, 53 both psychological and physical stressors can affect and activate this region.
Meanwhile, the correlation between adaptive behavioral responses due to severe stress and PVT
region of brain is still tangled. PVT is a part of the thalamic nuclei located at the midline and
intralaminar region and it is commonly assumed to participate in the arousal system.51 According
to neuroanatomical investigations,51-53 PVT collects autonomic and arousal projections of the
brainstem and nervous system. These studies have experimentally demonstrated PVT activation
by arousal and stress stimulators. Furthermore, it was recently shown that drug addiction behaviors
are also associated with this region of brain.54 In addition, substance addiction projections to the
prefrontal cortex, amygdala, and nucleus accumbens are likely to originate from the PVT region.55
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Despite the large population of patients affected by PTSD worldwide, there are no available
reports regarding the application of Raman spectroscopy or imaging for this type of brain disorder.
In order to understand the biochemical effects of PTSD on different regions of the brain which are
controlling vital functions, it is substantially important to monitor the lipid alterations in those
regions.32 Accordingly, novel therapeutic approaches can be developed to suppress these stressinduced changes. Recent studies illustrate the importance of stress-induced lipid metabolism
analysis and their huge impact on unravelling the functions of brain regions.3, 56 As a tangible
example, it has been reported that prolonged stress stimulates an important lipid enzyme
(phospholipase A2) which directly influences inflammatory responses by altering cellular lipid
signaling.57 Furthermore, stress-induced lipid modulations affect the PVT region by altering
arachidonoylglycerol and diacylglycerol levels.46 Additionally, ceramide level changes have also
been observed in the brain due to prolonged stress conditions.57
There is a growing interest in discovering novel therapeutics for the treatment and
molecular imaging methods for PTSD. We present new findings regarding the use of Raman
spectroscopy imaging for measuring lipid changes in the brain. Specifically, we describe an
approach for analyzing changes in the lipid levels in the PVT region of the brain tissue by obtaining
2D images of the formalin fixed brain sections from PTSD induced and control rats. We have used
both unbiased PCA analysis and targeted approaches using lipid standards to identify lipid classes.
We have validated the Raman imaging results with MALDI MS data. We anticipate that similar
studies can be accomplished in other regions of brain to better understand the impact of stressinduced modulations on behavioral and physiological responses in PTSD.
2. Materials and Methods
2.1. Biochemicals and Reagents
6

To build a Raman reference library, purified lipid standards such as phosphatidylinositol (P66361G), phosphatidylserine (P7769-25MG), phosphatidylethanolamine (P1348-25MG), cholesteryl
palmitate (C6072-1G), cholesterol (C8667-1G), galactocerebroside (C4905-10MG), glyceryl
tripalmitate (T5888-1G), phosphatidic acid (P4013-100MG) and sphingomyelin (S0756-100MG)
were purchased from Sigma-Aldrich (St. Louis, Missouri). Other lipids such as sulfatide (Avanti
# 131305) and ganglioside (Avanti # 860053) were purchased from Avanti Polar Lipids (Alabaster,
Alabama).
2.2. Brain Tissue Sample Preparation
Naive adult male Sprague-Dawley rats (n = 12) (Harlan Laboratories, Indianapolis, IN)
weighing 325-350 g with age of 10 weeks were used for this study. The animals were fed ad
libitum and kept under standard laboratory conditions (temperature: 20oC, humidity: 23 - 42%).
Alternating dark and light cycles (lasting 12 h each) was maintained. All animal handling
procedures was approved by the Institutional Animal Care and Use Committee (IACUC) of the
Louisiana State University School of Veterinary Medicine.
We used an acute predator exposure model38, 58-61 to induce traumatic stress in the animal.
In this model, rats were exposed periodically to a cat (adult, 7 years old, Harlan Laboratories,
Indianapolis, IN) followed by rotating the rats into different cages to eliminate any social support
and to induce chronic psychological stress. The experiments continued for 31 days and the rats
were exposed to the cat on day 1 and day 11 for 1 h. The first exposure was performed during the
daylight cycle (07:00 – 19:00), while the second exposure was performed during the night cycle
(19:00 – 07:00). Between Day 1 to Day 31, the rats were subjected to random cage rotation to
make sure that no rat was housed with the same set of rats on consecutive days or more than four
times within the experimental period. Also, it is important to note that during the exposure period,
7

the cat was not allowed to touch the rats by putting the rats in Plexiglas containers. Further, during
the cage rotation periods care was taken not to allow any cat or cat material near the cages. The
control group (n = 6) were not subjected to exposure to cat or cage rotation and were kept in the
same cages from Day 1-Day 31.
The behavioral test for anxiety was performed on all the rats using an elevated plus maze
(EPM) experiment (EB-Instruments, Bioseb, Tampa Bay, FL).38, 60, 61 In these experiments the rats
were allowed to roam freely for 5 min. and their movement were captured using an overhead
camera (BioEPM3C, EB-Instruments, Tampa Bay, FL). From the captured video, the number of
entries into each arm as well as the total time spent in the open vs. closed arms were extracted.
Compared with the control rats, the stressed rats avoided the open arm. The rats exposed to the cat
showed a decrease in the time spent at the open arm and an increase in the time spent at the closed
arm.38, 58-61 Further, the rats developing stress were identified through a label-free in vivo electron
paramagnetic resonance (EPR) test.38 The stressed rats showed an elevated level of reactive
oxygen species (ROS) in their brains compared to the control rats.38
The rats from the control and PTSD groups were humanely euthanized via inhalation of
carbon dioxide. Immediately after, transcardial perfusion was performed using 10 mM phosphatebuffered saline (PBS) solution. To fix the tissue, this step was followed by transcardial perfusion
with 4% phosphate-buffered paraformaldehyde (PB-PFA) solution. We immediately harvested the
whole brain using cranial dissection. The brains were cryosectioned into 40 µm thick slices that
were kept in 1X PBS at 4 °C. The tissue sections containing the paraventricular nucleus of the
thalamus (PVT) region were found by using the rat brain stereotaxic coordinates in the Bregma
number regions of -1.20 mm to -3.6 mm (see supplementary Figure S1).
2.3. Histology
8

Hematoxylin and Eosin (H&E) staining protocol was followed for the histology
observations. First, the nuclei were stained with alum hematoxylin. After rinsing, the samples were
dipped in acidified alcohol (1 ml concentrated HCl with 400 ml 70% ethanol). Afterwards, samples
were rinsed again and stained with eosin for 2 min. Finally, they were dehydrated and mounted on
standard 75 mm x 25 mm microscope slides.
2.4. Raman Spectroscopy and Microscopy
The Raman spectra of pure lipids in powder form were obtained with a Renishaw inVia
Reflex Raman Spectroscope with a 785 nm laser with an exposure time of 20 s and 100% power.
All the Raman spectra from brain samples were obtained under PBS (1X) immersion conditions
with an exposure time of 10 s, step size of 20 µm, objective lens of 50X (long-working distance)
and with high confocality. In spectral acquisition mode, from each sample at least ten spectra were
obtained for statistical analysis. In the imaging mode, for PTSD and Control samples 798 and 702
spectra were collected, respectively, to generate the Raman images. The machine was calibrated
using the silicon peak at 520 cm-1.
2.5. Data Processing and Statistical Analysis
All the Raman spectra were baseline corrected by Renishaw's WiRE 4.4 (Windows-based
Raman Environment) software. Preprocessing of the data and the subsequent principal component
analysis were performed by Origin 2018 (OriginLab, Northampton, MA). The Min-Max
normalization approach was applied to the datasets and smoothing was performed by means of the
Savitzky-Golay method. Direct classical least squares analysis (DCLS) method was used to
generate the mapping data. ImageJ 1.8 software was used for the quantification of Raman mapping
based imaging data. Figures S2-S4 demonstrate the steps for quantification of the Raman maps by
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means of pixel intensity and distribution. Accordingly, all the images were first converted into 8bit format. The weighted mean value of brightness (pixel value) as well as the regarding histogram
data were then calculated for all the pixels in an ROI by using the “Measure” function under the
“Analyze” tab of ImageJ software. This value is chosen as a representative for the relative
concentration of lipids (Figures S2 and S3). A color thresholding method was used to determine
the distribution of lipids. Based on the inspection of all the images, a brightness value of 111 (in
order to have a good contrast) was selected as a threshold in all the images. By keeping the
threshold constant, we analyzed the distribution of lipids in each Raman map (Figure S4).
The Raman spectral data were analyzed using principal component analysis (PCA).62-65
Multivariate analysis using the “Principal Component Analysis for Spectroscopy” toolbox of
Origin 2018 was used to perform the PCA. The spectral differences among the data sets were
described by the principal components (PC). Each of the Raman spectra is described as a point on
a score plot when selecting two or more PCs. Finally, the clustering of the data on the score plot
and their vibrational fingerprint assignment is obtained by the loading plot.
2.6. MALDI Analysis
A matrix assisted laser desorption/ionization (MALDI)-TOF/TOF mass spectrometer
(UltrafleXtreme, Bruker Daltonics, Billerica, MA, USA) was utilized for mass spectrometry
imaging (MSI) in positive ion mode. Brain slices were mounted on an indium tin oxide (ITO)
coated slides (UniversityWafer, Inc.). Super-DHB (Millipore-Sigma), 2, 5-dihydroxybenzoic acid
(DHB, Sigma-Aldrich), and α-cyano-4-hydroxycinnamic acid (Millipore-Sigma) were used as the
matrix.66 The matrix was prepared by dissolving super-DHB (1:1 ratio) in methanol and water
solution containing 0.1 vol% of trifluoroacetic acid, to a final concentration of 10 mg/mL. Tissue
sections were dried in a vacuum chamber for about 7 minutes. Afterwards, matrix was uniformly
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deposited on the tissue by means of pneumatic nebulizer (nitrogen gas pressure= 70 kPa; liquid
flow rate= 100 μL/min). Lamp heating was used to dry the matrix on the surface of the tissue. All
the MS data were smoothed by B-spline fit. A custom code, ‘Decimator.vi’ written in LabVIEW
VI (National Instruments) was utilized for baseline subtraction, averaging, decimation, and denoising of the obtained data. Bruker FlexAnalysis 3.0 software and MSiReader,67, 68 an opensource Matlab package, were employed for data analysis after baseline subtraction. Peak
assignments were done by using the available databases on lipidmaps.org. To generate MALDI
images, 1944 and 539 spectra were collected from PTSD and Control samples, respectively.
MALDI images were analyzed by using the same method used for Raman images, as described
above.
3. Results and Discussion
3.1. Raman Spectra for the PTSD and Control Tissue
Figure 1 shows an overview of this study from the animal model to output data. A predator
exposure/psychosocial stress regimen was utilized to develop PTSD in the rat. For verification of
PTSD induction, behavioral analysis, neurotransmitter changes, and oxidative stress analysis were
performed as described in the previous study.38 In order to demonstrate the location of the PVT
region in rat brain, Figure 2 shows H & E (Figure 2a, b), bright field (Figure 2c, d) and Raman
(Figure 2e, f) images of the control and PTSD brain tissues. Magnified PVT region is shown next
to the image of full brain slice. The PVT region is visible with a white color in H & E images and
a darker color in bright field images. Raman images (Figure 2e, f) were plotted at the peak position
of 1002 cm-1 for control and PTSD samples. This peak is the most abundant peak in most of the
biological samples. It is assigned to the aromatic ring C-C stretching mode and usually
demonstrates the existence of phenylalanine amino acid.35 Accordingly, the PVT region is
11

distinguishable from the surrounding area due to different contrast in all the three imaging
methods.
Figure 3a and 3b show the magnified view (12 X) of H & E images showing the PVT
region and the different neuron cell structures inside and outside of the PVT. Accordingly, no
morphological change was observed in the aforementioned region. To probe the biochemical
changes, Raman experiments were performed on the same region. Raman spectra of control
(Figure 3c) and PTSD (Figure 3d) samples illustrate the biochemical changes in the brain in the
PVT region due to the applied stress. The diagrams are achieved by plotting 30 different spectra
inside the dotted area for each sample. The average value is highlighted by darker colors for both
datasets. Raman bands of the brain spectra are assigned to cholesterol (608 cm-1), methionine (700
cm-1), DNA/RNA (847 cm-1), phenylalanine (1002 cm-1), acyl chains (C-C stretch; 1064 cm-1),
proteins (C-N stretch; 1127 cm-1), lipids (CH2 twist; 1300 cm-1), lipids (CH2 bend; 1439 cm-1).27
The Raman peak positions did not change significantly in the PTSD brain samples compared to
control samples (the assignment of all the Raman peaks are in Table S1). However, we found a
consistent modulation of Raman intensities between control and PTSD samples. Therefore, we
utilized principal component analysis (PCA) method to reveal any possible biochemical changes
in the PTSD brain samples. Significant changes were identified by the PCA and scatter plot that
were able to discriminate both sample groups, PTSD and control.
3.2. Raman Fingerprint Spectra Discriminates PTSD and Control
Figure 3e shows the score plot from the first two principle components based on 30 spectra
chosen from PTSD (pink) and control (blue) tissue samples. The score plot demonstrates a clear
segregation and distinct clustering of data obtained from different sample groups. Figure S5 also
shows the 3D view of the PCA analysis including the scatter plots from these first three PCs and
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it can distinguish the two sample groups as well. Figures 3f-3h show the box plot of the distribution
of spectral data for the two groups. The spectral data of the PTSD samples were significantly
shifted (P < 0.001) to the negative PC 1 range (median= -0.15) compared to control (median =
0.18; Figure 3f). Likewise, substantial changes (P < 0.05) were observed in the PC 2 (Figure 3g)
data distribution by shifting the median value from -0.14 in the control to 0.03 in the PTSD.
However, the changes in PC 3 (Figure 3h) were not significant (P > 0.05).
To find the biochemical components in each spectral variation, loading plots (Figures 3i,
3j, 3k) of the spectra obtained from the PVT region from PTSD and control are presented. The
loading plots demonstrate the major spectral differences of the PCs. The overall contribution from
the first three PCs is ~97.6 %. Characteristic peaks of each dataset are provided for PC 1, PC 2
and PC 3 (Figures 3i, 3j, 3k). These characteristic peaks indicate the differences in the various
Raman datasets. The loading plot for PC 1 (Figure 3i) was obtained from PTSD and control
samples and represents 90.5 % of the spectral variation includes the Raman peaks from all
biomolecules types (lipids, proteins, RNA and DNA). For example, 700 (methionine C-S trans),
1002 (phenylalanine C-C aromatic ring stretch), 1085 (phosphodiester groups in nucleic acids),
1300 (lipid CH2 twist) and 1438 cm-1 (lipid CH2 bend) are the prominent peaks for PC 1; 849
(amino acid stretch), 1002, 1300 and 1447 (proteins and lipids CH2 bending) cm-1 are the most
distinctive bands for PC 2 (Figure 3j). Moreover, the third compound of PC (Figure 3k) which
contains only 0.6 % of the spectral variation, can differentiate between proteins (1002 cm -1,
negative value) and lipids (1300 cm-1, positive value). As can be seen, some of the most significant
distinctive characteristics were observed in the lipid bands. As a result, a considerable change in
the concentration of lipids can be derived from the Raman spectra of PTSD brain compared to the
control sample. The in-depth discussion of lipid alterations is provided in the following.
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3.3. Raman Spectroscopic Comparison of Lipids Relevant to Brain Tissue
In order to track the lipid concentration changes in the rat brain due to acute stress exposure,
Raman spectra of the eleven most common lipids in brain32, 69-71 were acquired by collecting the
Raman signal from pure reference lipid samples by means of the 785 nm excitation laser. As can
be seen in Figures 4a – 4e, different lipids have different Raman spectra which distinguish them
from the other lipids. The spectral region from 400 – 1800 cm-1 shows the fingerprint region for
each lipid. The peaks in the wavenumber region 2700 – 3500 cm-1 are due to the CH, and OH
stretch (Figure S6). For instance, peaks from 2845 – 2868 cm-1 are due to the =CH2 symmetric
stretch, 2870 – 2904 cm-1 are from the =CH2 asymmetric stretch, peaks from 2905 – 2940 cm-1 are
due to the -CH3 symmetric stretch, 2941 – 2970 cm-1 are from the -CH3 asymmetric stretch, and
the Raman peaks from 3000 – 3015 cm-1 are due to the unsaturated =CH bond stretch.27 Figure 4a
shows the comparison of cholesterol (FC) and cholesteryl palmitate (or cholesterol ester, CE) (the
molecular structure is in Figure S7). The Raman band due to ester group at 1737 cm-1 is absent in
cholesterol. Spectral band at 1065, 1130, and 1297 cm-1 are due to palmitic acid group in the
cholesterol ester.69 The intense band at 1440 cm-1 is due to acyl group (CH2 or CH3 scissor).
Further, the following band shift was observed from cholesterol to cholesterol ester: 422 to 428,
548 to 538 (CH2 bend), 608 to 614 (ester group), and 1672 to 1667 cm-1 (C=C stretch).
Next, Figure 4b compares glyceryl palmitate (or triacylglyceride, TAG) and phosphatidic
acid (PA) (Figure S8). They share quite similar structures with one palmitic acid chain in TAG
replaced by a phosphate group for PA. The band due to ester group appears at 1737 cm-1 for PA.
The ester band for TAG splits into two at 1728 and 1743 cm-1 indicating that they are in a different
surrounding environment compared to PA. The three small bands at 587, 607, and 630 cm-1 are
due to glycerol.72 The band due to stretching of P-O vibration of PO4 group is at 993 cm-1.73 The
14

intense bands at 1061 (C-C stretch), 1130 (C-C stretch), 1297 (CH2 twist), and 1444 cm-1
(CH2/CH3 scissoring) are due to fatty acid chains. Figure 4c, d show the comparison of different
phospholipids. As shown in Figure S9, the parent group of phospholipids (PE, PI, PC, PS) is the
phosphatidic acid (PA). Therefore, the Raman bands of phospholipids share features similar to that
of phosphatidic acid. The band for phosphatidylethanolamine (PE) at 758 cm-1 is assigned to
ethanolamine (Figure 4c, Figure S10). Similarly, the band at 1095 cm-1 of the PE Raman spectrum
is due to phosphodioxy groups 𝑃𝑂2− (P-O stretch). At low wavenumbers between 200 -1000 cm-1,
distinct differences among phospholipids were observed (Figure 4d). Phosphatidylinositol (PI)
shows peaks at 234, 419, 523, 721, 770, 847, 873, 888, and 974 cm-1; Phosphatidylserine (PS)
shows peaks at 234, 524, 608, 753, 810, 848, 873, 888, 927, and 974 cm-1. The PI and PS have
bands at 1658 cm-1 (C=C stretch) which are absent in PA and PE. All the phospholipids have band
for ester (1739 cm-1) and acyl chains (1065, 1130, 1298, 1437 cm-1; Figure S10).
Figure 4e compares the Raman spectra obtained from sphingolipids (see Figure S11 for the
molecular structures). Sphingolipids are composed of lipids, a ceramide backbone, and glucose
rings with or without linker groups; the linker group for galactocerebroside (GalCer) is galactose,
sulfate containing monosaccharide for sulfatide (ST), and oligosaccharides for ganglioside (GM).
As seen in Figure S11 and S12 (also Figure 4e), Raman signature of lipids (at 1064, 1129, 1298,
1437 cm-1), ceramide backbone (1657, 1671 cm-1; C=C stretch), and sugar chain (1370 cm-1;
Figure S12) is clearly present. Figure S12 also shows that the area under the peak at 1370 cm-1 is
the highest for ganglioside (GM) and lowest for sphingomyelin (SM). This agrees well with the
molecular structure of GM, which has the maximum saccharide content (Figure S11) and that of
SM, which has no glucose group. Further, we observed that the peak ratio of 1370 (sugar chain)
to 1297 cm-1 (fatty acid) is the highest for GM. The Raman peak at 890 cm-1 (C-O-O skeletal
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mode) is present in all the sphingolipids except SM as SM does not have any C-O-O group (Figure
S13). The sulfate band in ST is characterized by 614 and 995 cm-1 (Figure S14).74 Finally,
sphingomyelin is composed of a phosphatidylcholine (PC) residue, which is characterized by
Raman peaks at 718 and 875 cm-1 (Figure 4e, S15). Another key difference between the backbone
of phospholipids and ceramide structure is the amide bond (1669 cm-1; Figure 4e, S15) in the
ceramide backbone instead of the ester band (1739 cm-1) of phospholipids.
Further, we utilized one-way multivariate statistical analysis coupled with the PCA
approach to separate different populations of lipids. PCA analysis was performed on the 11 most
common lipids found in brain tissue. Figure 4f represents the PCA scatterplot results obtained from
the first-derivative of the Raman data in various data sets of lipid spectra. The 95% confidence
ellipse of the clustered group PCA distribution is also shown in the plots. The PCA analysis of the
raw data did not cluster different classes of lipids separately and overlap among classes can be
seen (Figure S16a). However, after normalization, smoothing, and taking the 1st derivative of the
data, considerable separation among different lipid clusters was observed in the PCA results
(Figure S16b-d). Meanwhile, the second-derivative did not further improve separation of lipid
clusters. Therefore, it can be concluded that the first-derivative provides the best PCA results for
our data set (Figure 4f).
To include more variance among the data sets, PC 3 of the first-derivative was also
calculated to plot the 3D PCA result (Figure S16e). Figures 4g-4i show the PC values of firstderivative for different lipids. Each bar shows the mean value of the data. By performing ANOVA
on the PC 1 data set, it can be seen that the PC 1 value for every lipid is significantly different (P<
0.001) from the other lipids (see Table S2). Similarly, the same significant difference (P< 0.001)
was also observed for PC 2 data set except for phosphatidylserine vs. sphingomyelin,
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phosphatidylserine vs. ganglioside, and ganglioside vs. sphingomyelin (see Table S2).
Furthermore, the PC 3 data also showed significant differences (P< 0.001) for most of the lipids
(see Table S2). The corresponding loading plots of PC 1, PC 2, and PC 3 show the major peaks
responsible for the clustering of the data set (Figure 4j, 4k, 4l). The percentage variance described
by PC 1, PC 2, and PC 3 was 36.4%, 21.3%, and 9.8%, respectively. Analysis of the loading plots
showed that the prominent Raman peaks of the lipids show the most variance at 704 (characteristic
band for cholesterol), 1133 (acyl chain, palmitic and fatty acids), 1300 (lipid CH2 twist mode) and
1293 (methylene) cm-1 peak positions. As a result, it can be concluded that Raman spectra of the
most abundant lipids in the brain are statistically different from each other. Therefore, we can use
statistical methods to compare the lipid concentration in control and PTSD samples.
3.4. Raman Identifies Differences in Lipid Signature in PTSD and Control Brain Tissues
In order to compare the amount of lipid distribution in control and PTSD samples, we used
direct classical least squares analysis (DCLS) method.75-77 According to this model, the mixture
spectrum can be modeled as a linear mixture of various reference spectra. The DCLS model is
useful when reference spectra are available from pure samples. Accordingly, we first acquired the
Raman signal from the PVT region of both control and PTSD specimens. Afterwards, the Raman
spectra of pure lipids (Figure 4a-e) were used to quantify each lipid in terms of relative
concentration and distribution. Figures S17, S18 and S19 illustrate the Raman maps of eleven
commonly found lipids in the PVT region of the rat brain (the bars beside each image indicate the
value of the correlation coefficient between the corresponding lipid and brain spectra). After
plotting the respective maps for each lipid, ImageJ software was used to analyze the relative
concentration and distribution of lipids. To this end, the intensity value of brightness in each pixel
and also distribution of pixels is needed. The intensity values give the relative concentration
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change of each lipid. The distribution of pixel intensity describes the distribution of lipids in the
PVT region. For a tangible example, comparative Raman maps of cholesterol, galactocerebroside,
sulfatide and ganglioside are demonstrated in Figure 5a-5f. As can be seen, the relative
concentration of cholesterol and sulfatide is greater in the PTSD sample compared to the control.
In order to quantify the relative concentration values, we used pixel value which is a number
between 0-255. The value 0 indicates the minimum brightness and 255 indicates the maximum
brightness of a pixel. These values were obtained from 8-bit images by means of ImageJ software.
Figure S20 shows the pixel value distributions of different lipids in control and PTSD samples.
The relative shifts of the peaks to the right (higher pixel values), indicates an increase in the relative
concentration of lipids. Therefore, we can acquire the weighted mean value for each lipid from
this diagram that directly indicates the concentration changes of different lipids.
Figure 5g demonstrates the acquired weighted mean values for different lipids in PTSD
and control samples. Accordingly, the relative concentration of phosphatidylinositol,
phosphatidylserine, phosphatidylethanolamine, cholesteryl palmitate, cholesterol, sphingomyelin
and sulfatide experienced an increase by 23%, 44.6%, 20.6%, 10.2%, 35%, 32.2%, 54% in PTSD
sample, respectively. On the other hand, relative concentration of glyceryl tripalmitate and
ganglioside decreased by 47.1% and 23.3%, respectively, relative to control tissue. Meanwhile,
galactocerebroside and phosphatidic acid did not change noticeably. Stress response is followed
by the release of corticosterone.57 This hormone, which is derived from cholesterol, mediates the
pathologic responses of severe stress by binding to intercellular receptors. It is believed that the
concentration of neutral lipids (cholesteryl palmitate and cholesterol) in brain is correlated with
the level of corticosterone.1 Therefore, higher concentration of cholesterol indicates the higher
level of corticosterone in brain. Accordingly, the changes in lipid concentration have numerous
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impacts on physiological mechanisms of stress-related disorders. Changes in the concentration of
phospholipids (phosphatidylinositol, phosphatidylserine and phosphatidylethanolamine) and
sphingolipids (sphingomyelin, ganglioside, glyceryl tripalmitate and sulfatide) also reveal the
alteration of phospholipase A2 (PLA2) which is associated with inflammatory processes in
brain.57, 78
Apart from the relative concentration of lipids, we have also analyzed the areal distribution
of lipids in PVT region. The areal distribution is given as the percentage of occupied areal by each
lipid in PVT region (Figure 5h). By comparing the results from Figures 5g and 5h, it can be
observed that for some lipids (e.g. cholesterol and ganglioside), the distribution percentage of lipid
does not follow the trend of relative concentration. For example, for cholesterol, the lipid areal
distribution decreases slightly despite the increase in relative concentration of the lipid. Similarly,
for ganglioside the distribution percentage is almost constant while the relative concentration is
lower. The reason for the differences is due to the fact that we are not taking into account the pixel
intensity values while calculating the areal distribution percentage. In other words, we are using a
binary logic for distribution percentage to choose whether a pixel is ON (particular lipid is present)
or OFF (lipid is absent). Therefore, relative concentration and areal distribution should be utilized
side by side in order to achieve a fair judgment of lipidome alterations in the brain tissues.
3.5. MALDI-MS Imaging of Brain Tissue
To validate the Raman imaging results, we utilized MALDI mass spectrometry imaging
(MALDI-MSI) as a conventional lipidomic studies method to elucidate the role of lipids in PTSD.
The obtained lipidome profile is affected by the choice of ionization mode.79-84 Since wide range
of lipids can be ionized in positive mode, its widely used for lipidomics.79 However, phospholipids
such as PI, PS, and PA yield better results in negative ionization mode.85 Although we used both
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modes, only the MALDI images obtained in positive mode are shown here. The MALDI-MS
spectra obtained in the positive ion mode from the PVT region of the control and PTSD brain
tissue sample are shown in Figure 6a. The comparison of positive and negative ion mode spectra
is shown in the Supporting Information Figure S21. The MS spectra display both low molecular
weight (400 – 650 Da) and high molecular weight (700 – 1200 Da) lipid species. Positive ion mode
also allowed observation of low molecular weight lipids in the control brain tissue such as
lysophosphatidylcholines (LPC O-15:1, m/z 466.3), which are generally masked by the signal from
the matrix.86 Intense signal at m/z 663.4 for the control brain sample corresponds to PA 30:3;O3.
Other observed species were phosphatidylglycerols (PG 28:2, m/z 663.4). For the PTSD sample,
the intense mass peaks correspond to fatty acyls such as N-acyl taurines (NAT 20:4;O, m/z 466.2),
glycerophospholipids (PA 39:8, PG 33:3, PA 37:5, PG 31:0, PA O-38:5, PG O-31:1, PG 30:1, m/z
731.5; PC O-42:5, PC 41:5, PE 44:5, PC O-40:2, m/z 850.7), glycerolipids

such as

di(acyl|alkyl)glycerols (DG 42:8, m/z 731.5; DG 44:3, m/z 753.6), tri(acyl|alkyl)glycerols (TAG
43:3, m/z 753.6), and sphingolipids such as hexosyl ceramides (HexCer 42:1;O3, m/z 850.7).
Figure 6b shows the bright field optical image of the MALDI-MS sample. The distribution
of each lipid is shown in Figure 6c and 6e (also see Figure S22). We are able to observe the
pathological lipid changes in the PVT region of the brain due to PTSD. For example, the positive
ion image of sulfatides (ST 38:1, m/z 890.5; mFigure 6c) showed an accumulation of sulfatides
near the PVT of the PTSD rat. A similar elevated level of ST after traumatic brain injury was
observed in an earlier study.87 Figure 6d compares the Raman and MALDI image analysis results.
Figure 6d shows the ratio of PTSD to control calculated from the Raman images using the mean
value of pixel intensity (pink bars) for different lipids. The corresponding PTSD to control ratio
calculated from each MALDI-MS image (blue bars) is also compared with the Raman ratio. The
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ratio, R = 1 indicates no change, R > 1 indicates increase, and R < 1 indicates decrease of specific
lipids in PTSD samples compared to the control samples. Accordingly, an increase in the relative
concentration

value

of

phosphatidylinositol

(PI),

phosphatidylserine

(PS),

phosphatidylethanolamine (PE), cholesterol (FC), sphingomyelin (SM) and sulfatide (ST) is
observed by both Raman and MALDI imaging methods in the PTSD sample compared to the
control. Moreover, the decrease in the ganglioside (GM) and glyceryl tripalmitate (TAG) in the
PTSD sample was also confirmed by the MALDI images. No significant change was observed for
galactocerebroside (GalCer) and phosphatidic acid (PA) by any of the methods. Only cholesteryl
palmitate and glyceryl tripalmitate displayed a difference in its relative concentration between
MALDI detection and Raman detection. Therefore, the majority of the detected signals in MALDI
are in agreement with the Raman imaging analysis.
Figure 6e shows representative MALDI-MS images of selected lipid species in control and
PTSD brain samples.

The images were constructed using the following mass peaks:

phosphatidylserine (PS 34:2, m/z 760.5; PS 39:0, m/z 834.6; PS 39:7, m/z 842.5; PS 40:1, m/z
868.6; PS 43:4, m/z 882.6), phosphatidylinositol (PI 31:3, m/z 829.4; PI O-35:2, m/z 857.6; PI O37:3, m/z 883.6; PI O-37:2, m/z 885.6), sphingomyelin (SM 34:2-O2, m/z 723.5; SM 33:0-O2, m/z
729.5; SM 34:1-O2, m/z 741.5; SM 36:2-O2, m/z 767.5), phosphatidic acid (PA O-31:0, m/z 643.5;
PA O-33:1 & PA 32:1, m/z 647.5; PA O-35:3, m/z 671.5; PA 35:5, m/z 719.4), cholesterol (FC
24:5, m/z 401.2; FC 27:1-O, m/z 409.3; FC 26:2-O3, m/z 425.3; ST 27:1-O, m/z 425.3),
galactocerebroside (GalCer 34:1-O2, m/z 722.5; GalCer 40:2-O2, m/z 804.6; GalCer 40:1-O2,
m/z 806.6; GalCer 41:2-O2, m/z 834.6), triacylglyceride (TAG 50:9, m/z 817.6; TAG 52:9, m/z
845.7; TAG 50:2, m/z 869.7; TAG 52:3, m/z 895.7; TAG 58:13, m/z 921.7), cholesterol ester
(CE 18:3, m/z 669.6; CE 20:5 & CE 18:2, m/z 671.6; CE 22:0, m/z 731.7; CE 24:1, m/z 757.7),
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ganglioside (GM or Hex(3)-HexNAc-KDN-Cer 36:1-O2, m/z 1543.8; GM 36:1-O2, m/z 1562.9;
GM or Hex(4)-HexNAc-Fuc-Cer 36:1-O2, m/z 1563.9), phosphatidylethanolamine (PE 36:6, m/z
736.5; PE O-36:6, m/z 744.5; PE O-37:1, m/z 746.6; PE 37:6, m/z 750.5; PE 38:7, m/z 762.5;
PE O-36:3, m/z 766.5; PE O-37:1, m/z 768.6; PE 40:7, m/z 790.5; PE 39:0, m/z 790.6; PE 40:6,
m/z 792.6; PE 37:3, m/z 794.5; PE O-39:2, m/z 794.6).
The membrane lipid PI plays an important role in the signal transduction.88 Although
experiments performed in a different region of the brain (prefrontal cortex, PFC, and
hippocampus), Oliveira et al. also reported an increase of PI in the rat brain due to chronic stress.32
The increase of other phospholipids such as PE and PS reported in our study are supported by other
literature observations using neurodegenerative disease models.89-91 In addition to cholesterol and
phospholipids, sphingolipids are the most common membrane lipids in the brain.88,

92, 93

Sphingolipids such as gangliosides are implicated in brain development, memory formation as
well as synaptic transmission.94 Our results show a decrease in the gangliosides concentration in
PTSD samples, which is supported by the observations from Martin et al. and Kracun et al. using
the brain tissue of human subjects.95, 96 Further study by Oliveira et al. showed that the alteration
in lipid levels in the brain is area dependent. They observed an increase of the PI in the
hippocampus and a decrease in PE in the PFC, but no changes in the phospholipid levels in the
amygdala or cerebellum.97 These findings suggest that lipidome analysis should be performed in
specific areas of the brain for meaningful comparisons. Although the lipid distribution in the brain
is dynamic and complex, it is suggested to play some role in depression and anxiety disorders.3
The knowledge gained from this study may provide lipid-based targets for disease prevention and
treatment.
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4. Conclusion
In this study, we have evaluated the application of Raman spectroscopy and imaging for
the quantitative analysis of lipid concentrations in paraventricular thalamic nucleus (PVT) of posttraumatic stress disorder (PTSD), and control brain tissue. Raman spectroscopy provided a new
tool to non-invasively monitor the lipid changes in the brain tissue. Combining with histology and
MALDI mass spectrometry imaging, we have performed a parallel study with Raman imaging and
multivariate data analysis to validate the distinguishing of different lipids in brain tissue. Further,
we used a direct classical least squares analysis approach for rendering Raman maps and imaging
the lipid concentration in the PVT region. By means of this technique and various image processing
methods, we have demonstrated the relative alteration of lipids in PVT region before and after
inducing PTSD. Our results show a relative increase in the concentration of phosphatidylinositol
(28%), phosphatidylserine (43%), phosphatidylethanolamine (11%), cholesteryl palmitate (4%),
cholesterol (27%), sphingomyelin (37%) and sulfatide (58%) in the PTSD sample. Meanwhile, a
relative decrease in the concentration of glyceryl tripalmitate (71%) and ganglioside (32%) was
observed. However, the relative concentration of galactocerebroside and phosphatidic acid did not
change noticeably in the PTSD samples compared to the control. The higher relative concentration
of cholesterol and cholesteryl palmitate are directly related to the level of corticosterone.
Changes in the concentration of phospholipids and sphingolipids are associated with
inflammatory processes in the brain by changing the level of phospholipase A2 (PLA2). Similar
Raman imaging methods can be applied to other regions of brain and other types of brain disorders.
The Raman scattering-based label-free method could open new way to perform lipidomic studies
on cells and tissue with high spatial resolution for fast and non-destructive analysis.
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Supporting Information
Paraventricular nucleus of the thalamus (PVT) region inside rat brain; The method used
for quantification of Raman maps by means of pixel values; Quantification of phosphatidylinositol
base on pixel value method for control and PTSD samples; Calculating the areal distribution
percentage base on thresholding method; 3D view of PCA analysis; High-frequency region of
Raman spectra for different lipids; Comparison of cholesterol (FC) and cholesteryl palmitate (or
cholesterol ester, CE) chemical structures; Comparison of glyceryl palmitate (or triacylglyceride,
TAG) and phosphatidic acid (PA) chemical structures; Chemical structure of different
phospholipids (PE, PI, PC, PS); Comparison of the Raman spectra obtained from sphingolipids;
Raman spectrum of sphingomyelin; PCA analysis of the most common lipids in brain tissue for
raw data, normalized data, smoothed data and 2nd derivative data; Raman maps of
phosphatidylserine,

phosphatidylinositol,

phosphatidylethanolamine,

cholesterol,

galactocerebroside, glyceryl tripalmitate, phosphatidic acid, sphingomyelin, sulfatide, ganglioside
and cholesteryl palmitate in PVT region of the rat brain; Pixel value distributions of different
lipids; Comparison of positive and negative ion mode spectra; MALDI images acquired from PVT
region; Peak positions of Raman spectrum for control and PTSD samples; ANOVA with Levene
test for Homoscedasticity for the Raman spectra of the lipids
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Figure 1. Schematic showing the design of experiment. Brain tissue from control and PTSD rats
was obtained. Multivariate statistical analyses were performed on the Raman spectra and Raman
images to identify the biochemical changes in the paraventricular nucleus of the thalamus (PVT)
region of the brain.
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Figure 2. Histology and Raman imaging of brain tissues. H&E stained brain tissue of (a)
Control, and (b) PTSD rat. The inset zoomed image shows the paraventricular nucleus of the
thalamus (PVT) region. Bright field image of the brain tissue for the (c) Control, (d) PTSD rat.
The corresponding Raman imaging map at 1002 cm-1 collected using a λ = 785 nm laser is shown
for the (e) Control, and (f) PTSD rat. The inset shows the distribution of phenylalanine within the
PVT region.
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Figure 3. Raman spectroscopy, multivariate analysis, and associated histology images of the
PVT region. Representative H&E image of the PVT region for the (a) Control, (b) PTSD rat. The
corresponding mean Raman spectra of (c) Control, (d) PTSD brain tissue. The standard deviation
of all the spectra is shown as shaded color for each sample. (e) PCA score plot showing the
separation between PTSD and control tissue sample along PC 1. The distribution of score values
32

for (f) PC 1, (g) PC 2, and (h) PC 3. The corresponding loading plots highlighting the significant
peaks responsible for the separation in the score plot for (i) PC 1, (j) PC 2, and (k) PC 3.

*P <

0.05, **P < 0.01, ***P < 0.001, total number of spectra, n = 30.

Figure 4. Raman spectra and multivariate analysis for the reference standards of eleven most
abundant lipids in brain. The Raman spectra are grouped into lipid class such as sterol lipids,
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glycerolipids, phospholipids, and sphingolipids. Comparison of Raman spectra from 400 to
1800 cm-1 for (a) cholesterol (free cholesterol, FC), and cholesteryl palmitate (cholesterol ester,
CE); (b) glyceryl palmitate (triacylglyceride, TAG), and phosphatidic acid (PA); (c)
phosphatidylinositol (PI), phosphatidylserine (PS), and phosphatidylethanolamine (PE); (d) the
Raman spectra of phospholipids in the low wavenumber range of 200 – 1000 cm-1; (e) comparison
of Raman spectra from 400 to 1800 cm-1 for sulfatide (ST), ganglioside (GM), galactocerebroside
(GalCer), and sphingomyelin (SM). (f) Multivariate analysis showing one-way PCA scatter plot
of the first two principal components. The first derivate of the raw Raman spectra was performed
to construct the PCA score plot. (g, h, i) and (j, k, l) their corresponding loading plots are shown
for PC 1, PC 2, and PC 3, respectively.
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Figure 5. Comparison of DCLS Raman spectroscopy images of the lipids from the respective
PVT region. DCLS Raman heat maps of cholesterol (FC) and galactocerebroside (GalCer) plotted
from the signature Raman spectra for (a) Control, (c) PTSD brain sample. The Raman spectra are
shown in (b); (d-e) Raman heat maps and Raman spectra of sulfatide (ST) and ganglioside (GM);
Average of relative concentration of lipids within PVT region calculated from the (g) pixel
intensity, (h) areal distribution of the Raman images. Statistical significance were calculated using
Student's paired t-test, with a two-tailed distribution. *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
per group.
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Figure 6. Mass spectra and MALDI images obtained from the PVT region of the brain using
the positive ion mode. (a) Representative MALDI mass spectra acquired from the control (blue),
and PTSD (pink) brain sample. (b) Bright field optical image, and (c) False color two-dimensional
MALDI-MS image of sulfatides in control (top) and PTSD (bottom) sample (ST 38:1, m/z 890.5);
(d) Ratio of PTSD to control calculated from the Raman images using the mean value of pixel
intensity (pink bars) for different lipids. The corresponding PTSD to control ratio calculated from
each MALDI-MS images (blue bars) are also compared with the Raman ratio. Ratio, R = 1
indicates no change, R > 1 indicates increase, and R < 1 indicates decrease of specific lipids in
PTSD samples compared to the control samples. (e) Representative MALDI-MS images of
selected lipid species in control and PTSD brain samples. The images were constructed at the
following mass peak: phosphatidylserine (PS 34:2, m/z 760.5), phosphatidylinositol (PI 31:3, m/z
829.4), sphingomyelin (SM 33:0-O2, m/z 729.5), phosphatidic acid (PA 32:1, m/z 647.5),
cholesterol (FC 24:5, m/z

401.2), galactocerebroside (GalCer 34:1-O2, m/z
36

722.5),

triacylglyceride (TAG 50:9, m/z 817.6), cholesterol ester (CE 18:3, m/z 669.6), ganglioside (GM
or Hex(4)-HexNAc-Fuc-Cer 36:1-O2, m/z 1563.9), phosphatidylethanolamine (PE 36:6, m/z
736.5); the species number equal the total length and number of double bonds of both acyl chains;
mass error < 50 ppm.
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